Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 188

1.

Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.

Weitz JI, Hudoba M, Massel D, Maraganore J, Hirsh J.

J Clin Invest. 1990 Aug;86(2):385-91.

PMID:
2384594
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

The effect of antithrombin III-independent thrombin inhibitors and heparin on fibrin accretion onto fibrin-coated polyethylene.

Rubens FD, Weitz JI, Brash JL, Kinlough-Rathbone RL.

Thromb Haemost. 1993 Feb 1;69(2):130-4.

PMID:
8456425
[PubMed - indexed for MEDLINE]
4.

Inhibition of clot-bound and free (fluid-phase thrombin) by a novel synthetic thrombin inhibitor (Ro 46-6240), recombinant hirudin and heparin in human plasma.

Gast A, Tschopp TB, Schmid G, Hilpert K, Ackermann J.

Blood Coagul Fibrinolysis. 1994 Dec;5(6):879-87.

PMID:
7893925
[PubMed - indexed for MEDLINE]
5.

Sustained antithrombotic activity of hirudin after its plasma clearance: comparison with heparin.

Agnelli G, Renga C, Weitz JI, Nenci GG, Hirsh J.

Blood. 1992 Aug 15;80(4):960-5.

PMID:
1498336
[PubMed - indexed for MEDLINE]
Free Article
6.

Role of thrombin compared with factor Xa in the procoagulant activity of whole blood clots.

Prager NA, Abendschein DR, McKenzie CR, Eisenberg PR.

Circulation. 1995 Aug 15;92(4):962-7.

PMID:
7641380
[PubMed - indexed for MEDLINE]
Free Article
7.

The influence of direct and antithrombin-dependent thrombin inhibitors on the procoagulant and anticoagulant effects of thrombin.

Linder R, Frebelius S, Grip L, Swedenborg J.

Thromb Res. 2003 Jun 1;110(4):221-6.

PMID:
14512086
[PubMed - indexed for MEDLINE]
8.

Fibrin-targeted recombinant hirudin inhibits fibrin deposition on experimental clots more efficiently than recombinant hirudin.

Bode C, Hudelmayer M, Mehwald P, Bauer S, Freitag M, von Hodenberg E, Newell JB, Kübler W, Haber E, Runge MS.

Circulation. 1994 Oct;90(4):1956-63.

PMID:
7923685
[PubMed - indexed for MEDLINE]
9.

Evaluation of the inhibition by heparin and hirudin of coagulation activation during r-tPA-induced thrombolysis.

Mirshahi M, Soria J, Soria C, Faivre R, Lu H, Courtney M, Roitsch C, Tripier D, Caen JP.

Blood. 1989 Aug 15;74(3):1025-30.

PMID:
2502207
[PubMed - indexed for MEDLINE]
Free Article
10.

Effect of SanOrg123781A, a synthetic hexadecasaccharide, on clot-bound thrombin and factor Xa in vitro and in vivo.

Hérault JP, Cappelle M, Bernat A, Millet L, Bono F, Schaeffer P, Herbert JM.

J Thromb Haemost. 2003 Sep;1(9):1959-65.

PMID:
12941037
[PubMed - indexed for MEDLINE]
11.

Role of clot-associated (-derived) thrombin in cell proliferation induced by fibrin clots in vitro.

Gandossi E, Lunven C, Berry CN.

Br J Pharmacol. 2000 Mar;129(5):1021-7.

PMID:
10696104
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Effects of the synthetic thrombin inhibitor argatroban on fibrin- or clot-incorporated thrombin: comparison with heparin and recombinant Hirudin.

Berry CN, Girardot C, Lecoffre C, Lunven C.

Thromb Haemost. 1994 Sep;72(3):381-6.

PMID:
7855788
[PubMed - indexed for MEDLINE]
14.

Distinct effects of recombinant desulfatohirudin (Revasc) and heparin on plasma levels of fibrinopeptide A and prothrombin fragment F1.2 in unstable angina. A multicenter trial.

Rao AK, Sun L, Chesebro JH, Fuster V, Harrington RA, Schwartz D, Gallo P, Matos D, Topol EJ.

Circulation. 1996 Nov 15;94(10):2389-95.

PMID:
8921778
[PubMed - indexed for MEDLINE]
Free Article
15.

Inhibition by Argatroban, a specific thrombin inhibitor, of platelet activation by fibrin clot-associated thrombin.

Lunven C, Gauffeny C, Lecoffre C, O'Brien DP, Roome NO, Berry CN.

Thromb Haemost. 1996 Jan;75(1):154-60.

PMID:
8713795
[PubMed - indexed for MEDLINE]
16.

Dermatan sulfate is a more potent inhibitor of clot-bound thrombin than unfractionated and low molecular weight heparins.

Bendayan P, Boccalon H, Dupouy D, Boneu B.

Thromb Haemost. 1994 May;71(5):576-80.

PMID:
8091383
[PubMed - indexed for MEDLINE]
17.

Strategies for inhibiting the effects of thrombin.

Harker LA.

Blood Coagul Fibrinolysis. 1994 Jan;5 Suppl 1:S47-58; discussion S59-64. Review.

PMID:
8186356
[PubMed - indexed for MEDLINE]
18.

Platelet aggregation induced in vitro by rabbit plasma clot-associated thrombin, and its inhibition by thrombin inhibitors.

Gandossi E, Lunven C, Gauffeny C, Roome NO, Berry CN.

Thromb Haemost. 1998 Nov;80(5):840-4.

PMID:
9843181
[PubMed - indexed for MEDLINE]
19.

Evidence for thrombin enhancement of fibrin polymerization that is independent of its catalytic activity.

Kaminski M, Siebenlist KR, Mosesson MW.

J Lab Clin Med. 1991 Mar;117(3):218-25.

PMID:
2002278
[PubMed - indexed for MEDLINE]
20.

The acceleratory effect of thrombin on fibrin clot assembly.

Mosesson MW, Kaminski M.

Blood Coagul Fibrinolysis. 1990 Oct;1(4-5):475-8.

PMID:
2133225
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk